Publication | Open Access
Passive immunization with the anti-HIV-1 human monoclonal antibody (hMAb) 4E10 and the hMAb combination 4E10/2F5/2G12
104
Citations
25
References
2004
Year
This Phase I trial showed that the hMAb 4E10 can be safely administered, both alone and in combination with 2F5 and 2G12 to HIV-1-infected patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1